NCT02878291Unknown1 期
A Single-center, Open, Phase I Clinical Trial to Evaluate Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Occurrence of adverse events during a 30 day follow-up period after each vaccination
研究概览
简要总结
The purpose of this study is to evaluate safety of meningococcal ACYW135 polysaccharide conjugate vaccine in healthy volunteers aged above 3 Months
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 3 Months 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •3-11 months health infants who haven't immuned with Meningococcal A and C Conjugate Vaccine and population above 1 year old who have't given boost immunity.
- •Subject or legal representative who consent and has signed written informed consent.
- •Subject who did't immune with any live vaccine within 14 days and inactivated vaccine within 7 days before vaccination.
- •Subject and parent/guardian who is able to comply with all study procedures.
- •Axillary temperature ≤37.0 ℃.
排除标准
- •History of allergy，eclampsia, epilepsy, encephalopathy and mental disease or family disease.
- •Allergic history after vaccination.
- •History of meningitis infection disease.
- •Acute Febrile illness and Infectious Diseases.
- •Febrile illness (temperature ≥ 38°C) in the 3 days.
- •Immunodeficiency diseases patients who administered with immunosuppressive agents.
- •Children within 1 year old with abnormal labor, asphyxia rescue history,congenital malformations,genetic defects, eccyliosis or severe chronic disease.
- •Liver and kidney or cardiopulmonary disease，acute hypertension and diabetes.
- •In pregnancy or lactation or pregnant women.
- •Subject who plan to participate in or is in any other drug clinical trial.
- •Meningococcal vaccine contraindication.
- •Any condition that, in the judgment of investigator, may affect trial assessment.
结局指标
主要结局
Occurrence of adverse events during a 30 day follow-up period after each vaccination
时间窗: 30 day after each vaccination
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years OldMeningococcalNCT02867319Beijing Chaoyang District Centre for Disease Control and Prevention60
已完成
1 期
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001MeningitisNCT01661725Hualan Biological Engineering, Inc.60
进行中（未招募）
3 期
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 MonthsMeningitis, MeningococcalNCT05252715Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd1,200
进行中（未招募）
3 期
Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 YearsHealthy PopulationNCT06314685Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd2,450
已完成
2 期
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 MonthsMeningitis, MeningococcalNCT05229536Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd720